**Cigna Group Reports Fiscal Year 2025 Results, Navigating Divestitures and Strategic Shifts**
The Cigna Group (CI) released its 10-K filing, reporting total revenues of $274.9 billion for the year ended December 31, 2025, an 11% increase compared to $247.1 billion in 2024. This growth was primarily fueled by a 17% surge in pharmacy revenues, reaching $216.7 billion, driven by increased prescription drug utilization within the Evernorth Health Services segment. However, premiums experienced a 12% decline, settling at $40.3 billion, largely due to the divestiture of the Medicare Advantage business, which had a negative impact of 18%, partially offset by higher premium rates within the ongoing U.S. Healthcare businesses (+4%).
Shareholders' net income saw a substantial 73% increase, reaching $5.96 billion, compared to $3.43 billion in the previous year. This improvement was primarily attributed to the absence of impairment losses on VillageMD equity securities, which had significantly impacted the 2024 results. Adjusted income from operations, a key metric for the company, reached $8.01 billion, compared to $7.74 billion in 2024. Medical customers decreased by 5% to 18.1 million, primarily reflecting the impact of the completed sale of the Medicare Advantage business to Health Care Service Corporation (HCSC).
Operationally, The Cigna Group completed the sale of its Medicare Advantage and related businesses to HCSC on March 19, 2025, for $4.9 billion. The company also initiated a strategic optimization program aimed at improving efficiency and customer experience, incurring $749 million in pre-tax costs during the year. This program is expected to generate annualized after-tax savings of at least $500 million, with some savings already realized in 2025. The Evernorth Health Services segment saw a 16% increase in adjusted revenues, reaching $235.0 billion, driven by higher prescription drug utilization. Cigna Healthcare, on the other hand, experienced an 11% decrease in adjusted revenues, settling at $47.2 billion, primarily due to the Medicare Advantage divestiture.
Looking ahead, The Cigna Group is focused on executing its strategic and operational initiatives, including expanding its product portfolio, improving affordability, and leveraging data and analytics to enhance customer outcomes. The company is also committed to a rebate-free model for pharmacy benefits, which is expected to impact pre-tax adjusted income from operations for Evernorth Health Services in the short term. The Cigna Group's global workforce stood at approximately 67,700 employees as of December 31, 2025, with a continued focus on health, vitality, and diversity.
About Cigna Group
The Cigna Group is a global health company providing health, pharmacy, and care solutions through its segments, Evernorth Health Services and Cigna Healthcare. It offers medical, pharmacy benefit, specialty, and virtual care services to employers, health plans, government programs, and individuals worldwide. Its core value lies in delivering innovative, cost-effective, and high-quality healthcare solutions that improve health outcomes and vitality.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.